Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Database
Language
Publication year range
1.
Am J Transplant ; 12(2): 409-19, 2012 Feb.
Article in English | MEDLINE | ID: mdl-22221561

ABSTRACT

The presence of maternal cells in offspring may promote tolerance to noninherited maternal antigens (NIMAs). Children with biliary atresia (BA) have increased maternal cells in their livers, which may impact tolerance. We hypothesized that patients with BA would have improved outcomes when receiving a maternal liver. We reviewed all pediatric liver transplants recorded in the SRTR database from 1996 to 2010 and compared BA and non-BA recipients of maternal livers with recipients of paternal livers for the incidences of graft failure and retransplantation. Rejection episodes after parental liver transplantation were examined for patients transplanted at our institution. BA patients receiving a maternal graft had lower rates of graft failure compared to those receiving a paternal graft (3.7% vs. 10.5%, p = 0.02) and, consequently, fewer episodes of retransplantation (2.7% vs. 7.5%, p = 0.04). These differences were not seen among non-BA patients or among BA patients who received female deceased donor grafts. In patients transplanted at our institution, paternal liver transplantation was associated with an increased incidence of refractory rejection compared to maternal liver transplantation only in BA. Our data support the concept that maternal cells in BA recipients promote tolerance to NIMAs and may be important in counseling BA patients who require liver transplantation.


Subject(s)
Biliary Atresia/surgery , Graft Rejection/epidemiology , Graft Survival , Liver Transplantation/methods , Living Donors , Mothers , Adolescent , Adult , Biopsy , Child , Child, Preschool , Fathers , Female , Graft Rejection/pathology , Humans , Incidence , Infant , Infant, Newborn , Male , Middle Aged , Prognosis , Retrospective Studies , Risk Factors , Transplantation, Homologous , United States/epidemiology , Young Adult
2.
J Pediatr Surg ; 37(12): 1669-72, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12483626

ABSTRACT

BACKGROUND/PURPOSE: This study was designed to assess the outcome and financial costs incurred for the treatment of gastroschisis. METHODS: A retrospective analysis was conducted of all patients with gastroschisis at a single institution over the past decade (n = 69). Hospital costs were determined and standardized to December 2001 dollars. RESULTS: Of the 69 patients, average gestational age at delivery was 35.9 weeks. Thirty-six patients had a primary fascial closure; 33 had a silo placed. The mean time to first feeding was 22 days and full feeding, 33 days. Average length of stay was 47 days. There were 3 deaths (2 shortly after birth, and one 131 days later owing to sepsis). The average cost of hospitalization and physician fees for patients with gastroschisis was $123,200. Using multivariate regression analysis, significant variables (P <.05) associated with cost of hospitalization were number of operative procedures, ventilatory days, male gender, and length of stay. Room expenses (43%), physician fees (15%), respiratory and pulmonary care (10%), and supply and devices (10%) made up the majority of costs. CONCLUSIONS: Cost of care associated with treatment for gastroschisis is high. Strategies designed to reduce cost must limit gastrointestinal, respiratory, and operative complications and reduce length of stay.


Subject(s)
Gastroschisis/economics , Gastroschisis/surgery , Length of Stay/economics , California , Fees and Charges/statistics & numerical data , Female , Gastroschisis/mortality , Gestational Age , Health Care Costs , Humans , Infant , Infant, Newborn , Male , Maternal Age , Multivariate Analysis , Respiration, Artificial/economics , Retrospective Studies , Survival Rate , Treatment Outcome
3.
Yonsei Med J ; 42(6): 695-710, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11754153

ABSTRACT

Fetal endoscopic surgery (FETENDO) involves many techniques that allow surgical procedures to be performed inside the uterus without an hysterotomy. The impetus for developing these minimal access techniques for fetal surgery is the unusual occurrence with an open hysterotomy of preterm labor, premature rupture of membranes, and maternal complications resulting from tocolytic therapy. The unique requirements of this approach necessitated a modification of existing endoscopic techniques, the development of novel fetoscopic instruments, and the inclusion of a wide variety of specialists. Technical expertise in the field and a natural evolution of techniques have given rise to innovative repairs previously not envisioned. Severe congenital diaphragmatic hernia, diseases of monochorionic twins, and obstructive uropathy have already been successfully treated using fetoscopic surgical techniques. Fetoscopic correction of many other non-life threatening anomalies continues to evolve. The future of fetoscopic surgical intervention depends on the continual evolution of novel approaches to disease, the elucidation of the pathophysiology and treatment of other fetal disorders, and a better understanding of treatment of complications of such intervention.


Subject(s)
Fetal Diseases/surgery , Fetoscopy/methods , Anesthesia , Endoscopes , Female , Humans , Intraoperative Period , Operating Rooms , Pregnancy , Tocolysis , Ultrasonography, Prenatal
SELECTION OF CITATIONS
SEARCH DETAIL